Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853110 | PMC |
| http://dx.doi.org/10.1016/j.jpainsymman.2017.01.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correspondence: Reply to commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis".
Pharmacol Res
October 2024
Department of Nephrology, First Hospital of China Medical University, Shenyang, Liaoning, China; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer.
Br J Cancer
August 2024
Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.
RE: Reply to Rio-Vilariño and colleagues' article and misconception about YAP1 Ser 397 phosphorylation function.
Br J Cancer
June 2024
IOR, Dr. Rosell Oncology Institute, Dexeus University Hospital, 08028, Barcelona, Spain.
Reply to: revisiting the role of serine metabolism in hepatic lipogenesis.
Nat Metab
May 2023
Department of Chemistry, Princeton University, Princeton, NJ, USA.
In Reply: TSC/MTOR -associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum : Several Distinct Entities or a Tumor Family?
Am J Surg Pathol
April 2023
Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Jiangsu.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!